We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Store » Drug Products » Achieving ANDA Success: Working with the FDA to Win First-Cycle Approval
Other Options
PDF Edition
$397.00
PDF Edition - 3-4 Copies (10% Off)
$357.00
PDF Edition - 5-6 Copies (15% Off)
$337.00
PDF Edition - 7-9 Copies (20% Off)
$317.00
PDF Edition - 10+ Copies (25% Off)
$297.00
Achieving ANDA Success: Working with the FDA to Win First-Cycle Approval
Achieving ANDA Success Working with the FDA to Win First-Cycle Approval
Are you hoping for a one cycle approval of your ANDA?
This report explains how to meet the challenges and avoid the pitfalls in pursuing first-cycle ANDA approval including:
Advice on how to approach the FDA for guidance before you file your ANDA
How to work with Drug Master File holders and API suppliers to make the ANDA process go smoothly
Order your copy of Achieving ANDA Success: Working with the FDA to Win First-Cycle Approval today — applicants who get it right the first time can get their products to market quicker.
Order Your Copy Today
PDF Edition
Available Format
PDF Edition — $397
Who Will Benefit
Generic drug manufacturers
API suppliers
Submission and applications specialist
Strategic planning and lifecycle management specialists
Executive management
General/corporate counsel
Personnel new to the industry
Regulatory professionals
Consultants/service providers
Multi-user Access
Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Online Library — a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.
Our Guarantee
Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.